Page results
-
As part of Our National Health Stories, University College London Hospitals NHS Foundation Trust commissioned five poets to write and share stories from the NHS.
-
Contact the UCLH Media and Communications team. Read the UCLH magazine.
-
UCLH has formed a partnership with the Business Design Centre in Islington to deliver a second COVID-19 large scale vaccination centre.
-
The psychology team are running this workshop that uses a strengths based narrative approach to enable young people in years 10-13 to discuss the stresses surrounding exams and the additional challenges that having health problems add.
-
Jean Degala tells us how the right support, teamwork, effective communication, determination and dedication have helped her grow into the role.
-
Over 150 people visited a highly successful health and research engagement event in Camden which engaged the local community in healthcare innovation, research, and how to stay healthy.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
A research study has found that patients who get their chest X-ray results immediately are diagnosed in half the usual time.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
Contact the Patient Advice and Liaison Service (PALS)
File results
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer